Markets Stifel cuts Viveve Medical to hold; PT to $1 from $3 Stifel downgraded Viveve Medical (NASDAQ:VIVE) to “hold” from “buy” and lowered its price target to $1 from $3 after the company’s LIBERATE-International trial for stress urinary incontinence (SUI) missed its primary... July 23, 2019